These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7999346)

  • 1. Neurobiologic bases of noncognitive behavioral problems in Alzheimer disease.
    Raskind MA; Peskind ER
    Alzheimer Dis Assoc Disord; 1994; 8 Suppl 3():54-60. PubMed ID: 7999346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders.
    Ressler KJ; Nemeroff CB
    Depress Anxiety; 2000; 12 Suppl 1():2-19. PubMed ID: 11098410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathophysiology of agitation.
    Lindenmayer JP
    J Clin Psychiatry; 2000; 61 Suppl 14():5-10. PubMed ID: 11154018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychopharmacology of noncognitive abnormal behaviors in Alzheimer's disease.
    Raskind MA
    J Clin Psychiatry; 1998; 59 Suppl 9():28-32. PubMed ID: 9720484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dopaminergic neurotransmitter system is associated with aggression and agitation in frontotemporal dementia.
    Engelborghs S; Vloeberghs E; Le Bastard N; Van Buggenhout M; Mariën P; Somers N; Nagels G; Pickut BA; De Deyn PP
    Neurochem Int; 2008 May; 52(6):1052-60. PubMed ID: 18093695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologic markers and neurochemical correlates of agitation and psychosis in dementia.
    Kirby M; Lawlor BA
    J Geriatr Psychiatry Neurol; 1995 Oct; 8 Suppl 1():S2-7. PubMed ID: 8561841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuropathological principles of behavioral disorders in dementia].
    Umbricht DS
    Praxis (Bern 1994); 2000 Aug; 89(35):1362-5. PubMed ID: 11021191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Increased activity of stress-regulating systems in Alzheimer disease].
    Hoogendijk WJ; Meynen G; Feenstra MG; Eikelenboom P; Kamphorst W; Swaab DF
    Tijdschr Gerontol Geriatr; 2001 Feb; 32(1):17-23. PubMed ID: 11293840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Managing agitation and difficult behavior in dementia.
    Gray KF
    Clin Geriatr Med; 2004 Feb; 20(1):69-82. PubMed ID: 15062488
    [No Abstract]   [Full Text] [Related]  

  • 10. Cholinergic-serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer's disease.
    Garcia-Alloza M; Gil-Bea FJ; Diez-Ariza M; Chen CP; Francis PT; Lasheras B; Ramirez MJ
    Neuropsychologia; 2005; 43(3):442-9. PubMed ID: 15707619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-pharmacological and pharmacological treatment of the cognitive and behavioral symptoms of Alzheimer disease.
    Zec RF; Burkett NR
    NeuroRehabilitation; 2008; 23(5):425-38. PubMed ID: 18957729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The phenomenology of behavior: an overview of behavioral principles.
    Rabins PV
    Alzheimer Dis Assoc Disord; 1994; 8 Suppl 3():61-5. PubMed ID: 7999347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anticonvulsants in agitation and behavior disorders in demented subjects. Report of 8 cases].
    Fahs H; Potiron G; Senon JL; Perivier E
    Encephale; 1999; 25(2):169-74. PubMed ID: 10370890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioral abnormalities in Alzheimer's disease.
    Robert PH; Médecin I
    Ann Med Interne (Paris); 1998 Jun; 149(4):216-20. PubMed ID: 11490549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Agitation expressing pain in demented people with communication disorders].
    Pradines V; Pradines B
    Psychol Neuropsychiatr Vieil; 2004 Dec; 2(4):271-4. PubMed ID: 15683982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding pain in depression.
    Stahl S; Briley M
    Hum Psychopharmacol; 2004 Oct; 19 Suppl 1():S9-S13. PubMed ID: 15378669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain noradrenergic neurons, their interactions and role in the action of antidepressive drugs.
    Kostowski W
    Acta Physiol Pharmacol Bulg; 1982; 8(1-2):29-36. PubMed ID: 7124417
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanisms underlying the long-term behavioral effects of traumatic experience in rats: the role of serotonin/noradrenaline balance and NMDA receptors.
    Sziray N; Leveleki C; Levay G; Markó B; Hársing LG; Mikics E; Barsy B; Haller J
    Brain Res Bull; 2007 Jan; 71(4):376-85. PubMed ID: 17208655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noradrenergic and serotonergic abnormalities in depression: stress-induced dysfunction?
    Dinan TG
    J Clin Psychiatry; 1996; 57 Suppl 4():14-8. PubMed ID: 8636061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biological therapies of behavioral and psychological symptoms of dementia: update and prospects].
    Gallarda T; Olie JP
    Encephale; 2000; 26(3):72-80. PubMed ID: 10951909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.